bioRxiv Science⌕ Search

Biology subjects

Buccioli, G.

Publications and source records attributed to Buccioli, G..

2 recordsLinked to original sources

Engineering macrophage responses through 3D scaffold microarchitecture

Biomaterial implantation in living organisms triggers a physiological response known as foreign body reaction, leading to the recruitment of macrophages, that can polarize either into a pro-inflammatory (M1) or an anti-inflammatory (M2) phenotype. Currently, there is growing interest in tailoring the physical properties of tissues and biomaterials to promote efficient tissue regeneration. Tridimensionality can profoundly influence macrophage behaviour; however, there is no clear consensus on the underlying mechanisms. 3D microstructures may play a crucial role in modulating immune cells, promoting anti-inflammatory responses, and supporting effective tissue repair and regeneration. In this study, we used two-photon polymerization to fabricate 3D scaffolds with large pores, measuring 50x50x20 m3, and small pores, measuring 15x15x15 m3. Both microstructures effectively influenced macrophage cytoskeletal organization and cellular metabolic activity. Notably, they were not sufficient to induce spontaneous macrophage polarization, indicating that they are intrinsically immunologically inert. When combined with chemical stimulation, as typically occurs in vivo, they elicited distinct responses. Specifically, as evidenced by the slight upregulation of the Arg1 marker, large pore sizes promoted an anti-inflammatory phenotype. Conversely, iNOS expression measurements indicated that small pores, which impose spatial constraints on macrophages, favoured a massive pro-inflammatory state. Our results demonstrate that 3D microstructures are versatile tools for multiple applications. Their precisely tunable architecture enables fine control over macrophage behaviour and immunomodulation, opening new avenues both for tissue engineering, by preventing fibrosis and promoting anti-inflammatory and pro-regenerative responses in vivo, and for the development of in vitro platforms to model inflamed tissues for screening anti-inflammatory drugs.

bioengineering↗

The molecular basis of the anticancer effect of statins

Statins, one of the most used class of cardiovascular drugs with the primary function of reducing blood cholesterol levels, exert their effect by inhibiting the enzyme HMG-CoA reductase, the key player in cholesterol biosynthesis. While the primary indication for statins is the prevention of cardiovascular diseases, there has been growing interest in their potential anticancer effects. However, the current evidence on these effects is largely based on epidemiological observations and preclinical research, not yet substantiated by knowledge of the mechanisms behind it. Here we show that statins have an anticancer effect as they exploit the principle of Synthetic Lethality, a concept in which the combination of two non-lethal genetic or molecular events results in cell death or impairment. When either of these events occurs alone, it is not lethal, but when they happen coupled, they create a lethal condition for the cell. In this work we report that statins emerged from a computational data analysis that we performed on approximately 37,000 synthetic lethality couples. We performed this analysis to select repurposable drugs that could target genes involved in Synthetic Lethality couples with metastatic genes. We validated our discovery in vitro by drug tests performed on cell lines derived from cancers of the breast, ovary, and cervix. Our data-driven drug repurposing strategy allowed us to understand the molecular basis of the anticancer effect of statins, a discovery which can be directly translated into practical clinical applications in oncology.

cancer biology↗